The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Rock Creek Pharmaceuticals, Inc. - Drug Development Company Focused on Acute and Chronic Inflammatory Conditions

SNNLive spoke with Dr. Michael Mullan, CEO and Chairman of the Board for Rock Creek Pharmaceuticals, Inc. (OTCQB: RCPI) at Healthcare Week 2016 in San Francisco, CA.

Share With

Tuesday, February 09, 2016

   

© 2017 Stock News Now